Skip to main content
. 2018 May 17;9:233. doi: 10.3389/fendo.2018.00233

Figure 5.

Figure 5

Liraglutide reduced adipocyte size in both visceral and subcutaneous fat depots. (A) Mesenteric white adipose tissues (WAT) hematoxylin and eosin (HE) staining (magnification 200×). (B) Inguinal WAT HE staining (magnification 200×).